May 14, · Reading background research and writing and assignment in the context of formal education and academic studies should be informative and useful, which is why at Topics Mill online library, we have gathered this professional list of great titles for your next paper Jun 28, · The process of writing the research paper is going to be very time consuming so it’s important to select a topic that is going to sustain your interest for the duration of the project. It is good to select a topic that is relevant to your life since you are going to spend a long time researching and writing about it. Perhaps you are considering starting your own business or pursuing a career Jul 12, · A series of chapters from a childhood obesity plan have been the main developments: Childhood Obesity, A Plan for Action in August , Childhood obesity: a plan for action, Chapter 2 in June and Chapter 3 as part of the July green paper, Advancing our health: prevention in
Good Research Paper Topics [Updated August ]
What employers should consider as team members with diabetes return to the office. Peer-reviewed research evaluating the effect of the Virta Treatment demonstrates that patients can safely improve health outcomes associated with type 2 diabetes, obesity, atherogenic dyslipidemia, hypertension, and inflammation. By impacting these chronic conditions, the Virta Treatment improves several risk factors for type 2 diabetes and cardiovascular disease.
Visit the Virta Health blog to learn more about our thoughts on the latest research and hot topics in the field, research paper about obesity. How It Works. Join Now. Closing the Return-to-Work Gap What employers should consider as team members with diabetes return to the office.
Founded on decades of research and supported by ongoing clinical studies See our papers. Clinical Research paper about obesity Peer-reviewed research evaluating the effect of the Virta Treatment demonstrates that patients can safely improve health outcomes associated with type 2 diabetes, obesity, atherogenic dyslipidemia, hypertension, and inflammation.
Type 2 Diabetes While reducing and eliminating glycemic control medications, research paper about obesity, Virta patients lowered HbA1c by 1. View as table.
Obesity Excess weight represents risk for both type 2 diabetes and cardiovascular disease. Atherogenic Dyslipidemia Characterized by high triglycerides and low HDL-C, atherogenic dyslipidemia is common among patients with insulin resistance and represents increased cardiovascular risk. Hypertension Elevated blood pressure, especially in the presence of additional risk factors, increases cardiovascular risk.
Virta patients reduced blood pressure and the need for antihypertensive medication, especially diuretics. Inflammation Inflammation is a common underlying factor in obesity, insulin resistance, hypertension, research paper about obesity, and cardiovascular disease.
C-reactive protein and white blood cell count, common markers of inflammation, were significantly reduced in Virta patients with type 2 diabetes. Safety A common concern in the treatment of type 2 diabetes is hypoglycemia.
In our clinical trial, no hypoglycemic events requiring assistance were reported. Additionally, treatment at Virta resulted in neutral or positive effects on markers of kidney and liver function.
Cardiovascular Risk Markers year ASCVD risk score improves after one year of the Virta Treatment. Most lipid and lipoprotein risk markers improved or were unaffected; an undesirable change was observed in one marker.
Outcomes above were reported in Hallberg SJ et al. Diabetes Therapy. Cardiovasc Diabetol. Advancing science and medicine Virta Health Research is committed to improving patient health outcomes by advancing the understanding of chronic metabolic conditions and how to best treat them, while providing evidence to inform clinicians and patients in their care decisions. Peer-reviewed papers, research paper about obesity.
More than half of trial completers met the criteria for diabetes reversal, and a significant portion of those individuals also had partial and complete diabetes remission. Athinarayanan SJ, Adams RN, Hallberg SJ, et al. Long-Term Effects of a Novel Continuous Remote Care Intervention Including Nutritional Ketosis for the Management of Type 2 Research paper about obesity A 2-year Non-randomized Clinical Trial.
Frontiers in Endocrinology. doi: Continued improvement in health outcomes at 1 year After one year of treatment, patients who chose Virta improved glycemic control and markers of other chronic conditions. Other improvements included markers of cardiovascular disease, inflammation, and liver function.
Hallberg SJ, McKenzie AL, Williams P, et al. Effectiveness and Safety of a Novel Care Model for the Research paper about obesity of Type 2 Diabetes at One Year: An Open Label, Research paper about obesity, Controlled Study. McKenzie AL, Hallberg SJ, Creighton BC, et al. A Novel Intervention Including Individualized Nutritional Recommendations Reduces Hemoglobin A1c Level, Medication Use, and Weight in Type 2 Diabetes.
JMIR Diabetes. McKenzie AL, Athinarayanan SJ, McCue JJ, Adams RN, Keyes M, McCarter JP, Volek JS, Phinney SD, Hallberg SJ. Type 2 Diabetes Prevention Focused on Normalization of Glycemia: A Two-Year Pilot Study.
Long-term improvement in research paper about obesity risk factors Virta examined markers of cardiovascular disease at two-years and found that patients living with type 2 diabetes sustained improvements in multiple cardiovascular risk factors. This includes long-term improvement in traditional markers of atherogenic dyslipidemia triglycerides and HDL cholesterol and a substantial reduction in pro-atherogenic small LDL particles. Athinarayanan, S. et al. Impact of a 2-year trial of nutritional ketosis on indices of cardiovascular disease risk in patients with type 2 diabetes.
Cardiovasc Diabetol 19, research paper about obesity, Significant impact on cardiovascular risk factors For patients living with type 2 diabetes, the risk of cardiovascular disease Research paper about obesity is higher than average and CVD is the leading cause of mortality.
There is a need for interventions that mitigate cardiovascular risk in addition to improving glycemic control and markers of insulin resistance. On average, the Virta Treatment improved or had no effect on most markers of cardiovascular risk. For the subset of individuals whose key markers did not improve, the range of responses were similar to those observed in participants who pursued the usual care for their type 2 diabetes.
Bhanpuri NH, Hallberg SJ, Williams PT, McKenzie AL, Ballard KD, research paper about obesity, Campbell WW, McCarter JP, Phinney SD, Volek JS. Cardiovascular Disease Risk Factor Responses to a Type 2 Diabetes Care Model Including Nutritional Ketosis at One Year: An Open Label, Non-Randomized, Controlled Study.
Vilar-Gomez E, Athinarayanan SJ, Adams RN, et al Post hoc analyses of surrogate markers of non-alcoholic fatty liver disease NAFLD and liver fibrosis in patients with type 2 diabetes in a digitally supported continuous care intervention: an open-label, non-randomised controlled study BMJ Open ;9:e Improved patient-reported research paper about obesity quality Poor sleep quality and sleep disorders are common in patients with obesity and type 2 diabetes, but the relationship between these conditions is not yet understood.
Following one year of treatment, the global Pittsburgh Sleep Quality Index score and component scores related to quality, disturbance, and daytime dysfunction significantly improved among patients with research paper about obesity and type 2 diabetes.
Further, the proportion of patients classified as poor sleepers was significantly reduced at one year. Siegmann MJ, Athinarayanan SJ, Hallberg SJ, et al. Improvement in Patient-Reported Sleep in Type 2 Diabetes and Prediabetes Participants Receiving a Continuous Care Intervention with Nutritional Ketosis.
Sleep Medicine. Ongoing Research. IUH Clinical Trial In collaboration with researchers and clinicians at IU Health Arnett, the primary purpose of this clinical trial is to demonstrate the therapeutic effects of the intervention over 2 years in participants with type 2 diabetes, prediabetes, and metabolic syndrome.
Secondary purposes include assessing for differences in therapeutic effects of the intervention between patients who self-select onsite vs. web-based education delivery, exploring relationships between change in LDL cholesterol and carotid intima media thickness, and evaluating the sustainability of health outcomes achieved and the economic impact of therapeutic effects over 5 years. Virta Health Registry for Remote Care of Chronic Conditions The purpose of this registry is to establish a research data repository, comprised primarily of data generated in the course of clinical care, to conduct research on Virta Health clinical interventions and the chronic conditions present in Virta Health patients.
White Papers. In this white paper, we discuss participant retention and health outcomes achieved by participants with type 2 diabetes after six months. The Cardiovascular Benefits of the Virta Treatment Cardiovascular disease is the number one cause of morbidity and mortality in patients with type 2 diabetes. Here we discuss the impact of the Virta Treatment on risk factors for cardiovascular disease including hypertension, atherogenic dyslipidemia, LDL partitioning, inflammation, insulin resistance, research paper about obesity, obesity, liver function, carotid intima media thickness, medications, research paper about obesity, and composite risk scores.
Together these findings suggest near-term and projected long-term improvement in cardiovascular risk. Science and research research paper about obesity Visit the Virta Health blog to learn more about our thoughts on the latest research and hot topics in the field. Read Blog.
Pregnancy: A Teachable Moment for Weight Control and Obesity
, time: 33:07Research | Virta Health
May 14, · Reading background research and writing and assignment in the context of formal education and academic studies should be informative and useful, which is why at Topics Mill online library, we have gathered this professional list of great titles for your next paper Jun 07, · A research paper is just as its name suggests — a form of academic writing that necessitates the independent investigation of a specified topic and reports the unique results of that investigation. Suny Empire State College provides a great and exhaustive explanation of what a research paper is Purpose of review: The purpose of this paper is to review the epidemiology of obesity and the evolution of artificial sweeteners; to examine the latest research on the effects of artificial sweeteners on the host microbiome, the gut-brain axis, glucose homeostasis, and energy consumption; and to discuss how all of these changes ultimately contribute to obesity
No comments:
Post a Comment